Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter April 16, 2014

Correlation between neopterin levels in premature infants with sepsis and the signs and symptoms of neonatal sepsis using the Töllner sepsis score

Mohamad Yanuar Anggara, Dida Akhmad Gurnida and Sjarif Hidajat Effendi
From the journal Pteridines


Neonatal sepsis in premature infants is difficult to diagnose, and available markers are still varied. Neopterin is a derivative of pyrazino-pyrimidine produced by macrophages when stimulated by interferon γ. This study aimed to measure and compare the concentration of serum neopterin between groups of neonates with and without sepsis, and its correlation with Töllner’s sepsis score (TSS). This analytic observational study with a cross-sectional design included 46 premature infants with (n=23) and without neonatal sepsis (n=23). Data analysis using the Mann-Whitney U-test was performed to compare the levels of neopterin in premature infants with and without neonatal sepsis, and the Spearman rank correlation test to determine the correlation between neopterin levels and TSS. Neopterin levels in the sepsis group were higher than in the non-sepsis group (116 vs. 41.1 nmol/L; p<0.001). This study also showed a positive correlation between neopterin levels in premature infants with neonatal sepsis and TSS (r=0.776, p<0.001). Neopterin levels were higher in premature infants with neonatal sepsis than in those without it and positively correlated with TSS.


Although mortality rates for children aged <5 years have improved in many countries worldwide, neonatal mortality rates (deaths in the first 28 days of life) have shown little improvements. Neonatal mortality rate now accounts for >42% of deaths in children aged <5 years, up from 37% in 2000 when the Millennium Development Goals (MDGs) were set [1]. Infections account for about 36% of these deaths. Neonatal sepsis is a clinical syndrome caused by a systemic response to infection during the first month of an infant’s life [2]. One study showed that, compared with term infants (TI), premature infants (PI) have as much as 4.8 times higher risk of sepsis [3].

Early signs of sepsis are often non-specific, which results in inadequate treatments. To accurately identify neonates with sepsis, attempts have been made to use physiologic parameters, hematologic indices, and cytokine profiles. C-reactive protein (CRP) and procalcitonin levels have been widely used as markers to diagnose sepsis. However, in PI, the increase in CRP level often occurs at postnatal age >48 h [4, 5]. Procalcitonin level is a sensitive marker, but, like CRP, often gives false-negative results. The procalcitonin test is also more expensive to perform [5, 6].

Neopterin is a derivative of pyrazino-pyrimidine formed by guanosine triphosphate in the tetrahydrobiopterin synthesis pathway. The derivatives are produced by macrophages when stimulated by interferon γ (IFN-γ) produced by T lymphocytes [7]. Increased neopterin level has been shown to be a sensitive and specific marker in cellular immune activation in certain conditions such as allograft rejection, bacterial infections, and malignancy [8, 9]. Research on the role of neopterin in the diagnosis of sepsis in PI has not been conducted before in Indonesia.

The purpose of this study was to measure and compare the value of serum neopterin in PI with and without sepsis, and to determine the correlation between neopterin levels and the signs and symptoms of neonatal sepsis using the Töllner sepsis score (TSS) [10].

Materials and methods

This is an analytic observational study with a cross-sectional design. Inclusion criteria were appropriate-for-gestational age premature infants (30–36 weeks of gestation), with and without neonatal sepsis, and who were referred to or delivered at the Department of Child Health, Hasan Sadikin Hospital. TSS was calculated for each patient. In developing countries, a different scoring system is often used to help diagnose neonatal sepsis, so we cannot depend exclusively on culture results. We used TSS because it included both laboratory parameters, such as leukocyte and thrombocyte counts, CRP, and immature/total neutrophil ratio, and clinical parameters, such as skin color, body temperature, muscle tone, breath rate, abdominal distension, and imperfect microcirculation [10, 11]. A point was given for each parameter (0, 1, 2, or 3), according to its severity (e.g., 0 for normal muscle tonus, 1 for hypotonia, and 2 for flaccid tonus; 0 for normal leukocyte count, 1 for leukocytosis, and 3 for leukopenia). Infants with sepsis were defined as having a TSS of ≥10. No infants should have a history of antibiotic use, be in a critical condition, or have congenital abnormalities.

An additional 1 mL of blood was taken from the tubes, then centrifuged at 3500 rpm for 10 min; subsequently, 0.5 mL of serum was taken from the blood samples and neopterin serum level was determined using the Neopterin ELISA Kit (IBL, Hamburg, Germany). These tests were species specific, and a level of >10 nmol/L during the first 48 h was considered as elevated. The study was conducted after obtaining approval from the Health Research Ethics committee of the Faculty of Medicine of Padjadjaran University, Hasan Sadikin Hospital.

All data obtained were recorded and tabulated, then the Mann-Whitney U-test was used to compare the levels of neopterin in PI with and without sepsis, whereas the Spearman rank correlation test was used to determine any correlation between neopterin levels and TSS. Data analysis was performed using SPSS for Windows version 17.0. A p-value of ≤0.05 was considered to indicate significance.


The study was conducted from May to July 2013. During the first 3 months of the study, there were 46 PI, divided equally into the sepsis group and the non-sepsis group.

Table 1 shows that sepsis is more common in male infants, with a mean premenstrual age of 35 weeks (range, 30–36 weeks), mainly vaginally delivered, and with a mean birth weight of 1912 g (range, 1250–2400 g). Characteristics data of both the sepsis and the non-sepsis group were not significantly different (p<0.05), indicating a homogeneous distribution of infants in both groups.

Table 1

General characteristics of neonatal subjects.

CharacteristicsSepsis group (n=23)Non-sepsis group (n=23)p-Value
Gestational age, weeks0.793
 Mean35 (1.8)34 (1.48)
 Vaginal birth2019
 Non-vaginal birth34
Birth weight, kg0.823
 Mean1912 (25.7)1893 (33.5)

Table 2 shows that neontal sepsis was predisposed by several maternal risk factors, with premature rupture of membrane (PROM) occurring in eight neonates (34.8%), meconeal amniotic fluid occurring in seven infants (30.4%), and maternal fever during delivery in two infants (8.7%). Only in meconeal amniotic fluid levels did the two groups differ significantly (p=0.004).

Table 2

Maternal risk factor for sepsis.

CharacteristicsSepsis group (n=23)Non-sepsis group (n=23)p-Value
PROM >24 h830.084
Amniotic meconeal fluid700.040
Maternal fever200.148
Diabetic mothers00a

PROM, premature rupture of membrane. aThe test was not conducted.

Blood cultures were performed in all infants with sepsis. A positive culture result was only obtained from seven subjects (30.4%). The most common species were Klebsiella peneumoniae in four subjects (57% positive cultures), whereas in the other three subjects, Staphylococcus hemolyticus, Serratia marcesens, and Alcaligus faecalis were identified by culture.

The serum concentration level of neopterin in the sepsis group had a mean of 116±49.9 nmol/L (range, between 51.3 and 177 nmol/L; median, 129 nmol/L), whereas in the non-sepsis group the mean was 41.1±9.04 nmol/L (range, between 21.1 and 66.4 nmol/L; median, 41 nmol/L). The level of serum neopterin was significantly higher in the sepsis than in non-sepsis group (p<0.001).

Figure 1 shows a positive correlation between levels of neopterin in PI with sepsis and TSS (r=0.776, p<0.001), indicating that the higher the TSS, the higher the neopterin levels.

Figure 1 Correlation between neopterin levels and Töllner sepsis score.

Figure 1

Correlation between neopterin levels and Töllner sepsis score.


In this study, sepsis was more prevalent in male infants with low birth weight, who were born spontaneously, and who have a history of maternal meconeal amniotic fluid, premature rupture of membranes after >24 h, and maternal fever before labor. However, only maternal meconeal amniotic fluid was significantly different (p<0.05) in the non-sepsis group. Utomo [12] also reported that sepsis mainly occurs in low-birth-weight male infants with meconeal amnitotic fluid history. Shah et al. [13] reported that sepsis was more common in infants with low birth weight, a history of birth asphyxia, and maternal meconeal amniotic fluid. A wider scale research is needed to analyze the characteristics of neonatal sepsis in Indonesia.

In sepsis, bacteremia begins with the colonization of bacteria that most commonly occurs in the airway mucosa, intestinal tract, and urogenital tract. After the colonization, the bacteria then penetrate the epithelial cells (transcellular, paracelullar, or intracellular). This condition then leads to the activation of granulocytes or mononuclear cells to detect the bacteria by the phagocytosis process. This process is then followed by the introduction of pathogens through pathogen-associated molecular patterns (PAMPs) that will be recognized by toll-like receptors (TLRs) [14].

The introduction of pathogens will further activate the immune process. The immune system will initiate the inflammatory response by secreting cytokines and chemokines that will induce molecules to attract other immune cells to the site of infection and trigger an adaptive immune response. T lymphocytes will recognize the antigen, inducing them to secrete lymphokines [14, 15].

IFN-γ is the central stimulus for the activation of GTP-cyclohydrolase. Once GTP-cyclohydrolase I is activated, fibroblasts or the endothelial cells will then produce tetrahydrobiopterin. However, because of the relative deficiency of 6-pyruvoyl-tetrahydropterin synthase in humans and primates, the activation of GTP-cyclohydrolase leads to the accumulation of 7,8-dihydroneopterin triphosphate, which is converted by phosphatases to neopterin and 7,8-dihydroneopterin [16].

Our study subjects had somewhat higher levels of neopterin than subjects in previous studies. Boseila et al. [9] reported a cut-off point of 32 nmol/L with a mean level of 66.5±24 nmol/L in the sepsis group and 12.8±9.7 nmol/L in the non-sepsis group. Another study conducted by Radunovic et al. [17] showed that the neopterin level in PI with no sepsis was 7.2±2.1 nmol/L for infants at 30–35 weeks of gestation and was 9.2±2.2 nmol/L for infants at 35–37 weeks of gestation. This result may have been caused by the different patterns of environmental condition, hygiene, and microorganisms involved in neonatal sepsis between developed and developing countries.

Extremely high concentrations of neopterin in the serum and urine were observed during acute viral infection compared to during acute bacterial infection. Neopterin alone, or even better in combination with CRP, is a very useful marker for supporting the differential diagnosis of viral vs. bacterial infections [18, 19]. Our study did not determine viruses as the etiology of sepsis.

About 78.2% of infants with sepsis in our study had maternal risk factors such as a history of fever and of meconeal amniotic fluid. This condition may have heightened the neopterin levels since the intrauterine period. Ip et al. [20] showed that meconeal amniotic fluid or premature rupture of membranes could lead to elevated levels of neopterin. High neopterin levels are also probably due to the differences in genetic factors between developed and developing countries. The response of interferon gene expression is influenced by several genes, e.g., the interferon-β1 (IFN-β1) gene, the 2′-5′-oligoadenylate synthetase (OAS1) gene, and the 2′-5′-oligoadenylate synthetase (OAS2) gene. Carthagena et al. [21] found that the expression of genes influences interferon response and that the expression of these genes may differ between individuals. High levels of neopterin can also be explained by the hygiene hypothesis. It is probable that the presence of infection by bacteria or viruses in a sterile condition such as in the intrauterine period will activate the immune system, which could increase the levels of regulatory T cells, resulting in higher neopterin levels [22].

Limitations of this study include the following: viral culture was not conducted; viral infection is probably one factor that influences the high levels of neopterin. This study did not carry out either any long-term monitoring of infants with sepsis to assess the prognosis of this infection. Another limitation is that we did not determine the cut-off point of neopterin levels owing to the small sample size, nor did we compare the possible superiority of neopterin to CRP or procalcitonin as a marker for infection. However, this study could be used as an initial or baseline research for further, larger research on neopterin levels in PI, especially in developing countries like Indonesia.

In conclusion, neopterin levels are higher in PI with sepsis than in those without. Neopterin levels positively correlated with the signs and symptoms of neonatal sepsis, as indicated by TSS. The higher levels of neopterin in the sepsis group with intrauterine risk factors could probably activate cellular immunity even during the intrauterine period.

Corresponding author: Mohamad Yanuar Anggara, Medical Faculty, Department of Child Health, Universitas Padjadjaran, Hasan Sadikin Hospital, Jl. Pasteur No. 38, Bandung 40161, Indonesia, E-mail:


1. Lawn JE, Gavett MG, Nunes TM, Rubens CE, Stanton C. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth 2010;10:1–22.10.1186/1471-2393-10-S1-S1Search in Google Scholar PubMed PubMed Central

2. Chacko B, Sohi I. Early onset neonatal sepsis. Indian J Pediatr 2005;72:23–6.10.1007/BF02760574Search in Google Scholar PubMed

3. Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004;51:939–59.10.1016/j.pcl.2004.03.009Search in Google Scholar PubMed

4. Bomela HN, Ballot DE, Cory BJ, Cooper PA. Use of C-reactive protein to guide duration of empiric antibiotic therapy in suspected early neonatal sepsis. Pediatr Infect Dis J 2000;6: 23–32.10.1097/00006454-200006000-00008Search in Google Scholar PubMed

5. Santana RC, Garcia-Muñoz F, Reyes D, Gonzalez G, Dominguez C, Domenech E. Role of cytokines (interleukin-1β, 6, 8, TNF-α, and soluble receptor of interleukin-1) and C-reactive protein in the diagnosis of neonatal sepsis. Acta Pediatr 2003;92:221–7.Search in Google Scholar

6. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal 2004;89:F229–35.10.1136/adc.2002.023838Search in Google Scholar PubMed PubMed Central

7. Berdowska A, Zirska-korczala K. Neopterin measurement in clinical dagnosis. J Clin Pharm Ther 2001;26:319–29.10.1046/j.1365-2710.2001.00358.xSearch in Google Scholar PubMed

8. Bornadio WA, Smith D, Carmody J. Correlating CBC profile and infectious outcome: a study of febrile infants evaluated for sepsis. Clin Pediatr J 1992;10:578–84.10.1177/000992289203101001Search in Google Scholar PubMed

9. Boseila S, Seoud I, Samy G, El-Gamal H, Ibrahim TS, Ahmed A. Serum neopterin level in early onset neonatal sepsis. J Am Sci 2011;7:343–52.Search in Google Scholar

10. Tollner U. Early diagnosis of septicemia in the newborns. Eur J Pediatr 1982;138:331–7.10.1007/BF00442511Search in Google Scholar PubMed

11. El-Wakeel MA, El-Kassas GM, Fathy GA, El-Wakkad AS, Sebaii HM, El-Zayat SM. Diagnostic and prognostic values of high sensitive c-reactive protein, tumor necrosis factor and interleukin-1β in neonatal sepsis. Aust J Basic Appl Sci 2012;6:224–8.Search in Google Scholar

12. Utomo TM. Risk factors of neonatal sepsis: a preliminary study in Dr. Soetomo Hospital. Indon J Trop Infect Dis 2010;1:23–6.10.20473/ijtid.v1i1.3718Search in Google Scholar

13. Shah GS, Budhathoki S, Das BK, Mandal RN. Risk factors in early neonatal sepsis. Kathmandu Univ Med J 2006;4:187–91.Search in Google Scholar

14. Pollin RA. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012;129:1006–15.10.1542/peds.2012-0541Search in Google Scholar PubMed

15. Huttunen R, Aittoniemi J. New concept in the pathogenesis, diagnosis, and treatment of bacteremia and sepsis. J Infect 2011;63:407–19.10.1016/j.jinf.2011.08.004Search in Google Scholar

16. Murr C, Widner V, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab 2002;3: 175–87.10.2174/1389200024605082Search in Google Scholar

17. Radunovic N, Kuczynski E, Rebarber A, Nastic D, Lockwood CJ. Neopterin concentrations in fetal and maternal blood: a marker of cell-mediated immune activation. Am J Obstet Gynecol 1999;181:170–3.10.1016/S0002-9378(99)70455-2Search in Google Scholar

18. Greksova K, Parrak V, Chovancova D, Stenel P, Oravee J, Marsik L. Procalcitonin, neopterin and C-reactive protein in diagnostics of intrauterine infection and preterm delivery. Bratisl Lek Listy 2009;110:623–6.Search in Google Scholar

19. Plata-Nazar K, Jankowska A. Clinical usefulness of determining of concentration of neopterin. Pteridines 2011;22:77–89.10.1515/pteridines.2011.22.1.77Search in Google Scholar

20. Ip M, Rainer TH, Lee N, Chan C, Chau SS, Leung W, et al. Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. Diagn Microbiol Infect Dis 2007;59:131–6.10.1016/j.diagmicrobio.2007.04.019Search in Google Scholar PubMed

21. Carthagena L, Bergamaschi A, Lina JM, Annie D, Pradeep D. Human TRIM gene expression in response to interferon. PLoS One 2009;4:E4894–8.10.1371/journal.pone.0004894Search in Google Scholar PubMed PubMed Central

22. Bufford JD, Gern JE. The hygiene hypothesis revisited. Immunol Allerg Clin North Am 2005;25:247–62.10.1016/j.iac.2005.03.005Search in Google Scholar PubMed

Received: 2014-2-2
Accepted: 2014-3-19
Published Online: 2014-4-16
Published in Print: 2014-7-1

©2014 by Walter de Gruyter Berlin/Boston

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.